| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86bd6bf5a2cb8ba68b45b2c4a13e6b14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
1984-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1985-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_344a76931a4a19475ead167caec6c04f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a77f4a48214364fc92aefc57f1c2f6 |
| publicationDate |
1985-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4550175-A |
| titleOfInvention |
Process for the stereospecific preparation of (Z)-1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)-0-(2,4-dichlorobenzyl)-ethanone oxime ether |
| abstract |
For preparing substantially pure (Z)-1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)-0-(2,4-dichlorobenzyl)-et hanone oxime ether having the formula <IMAGE> (I) i.e. the cis-isomer of said oxime ether in a stereospecifically pure form, the pure (Z)-stereoisomer of the corresponding ethanone oxime is first converted into an alkali salt in a polar solvent, such as acetone or dimethylformamide, using an alkali in an amount somewhat less than the equimolar amount with respect to the said ethanone oxime, and is then converted to the desired ether by reacting it at a temperature not higher than 40 DEG C. with a halogen compound capable of forming the desired ether. Isolation of the ether product is obtained as the free base or by precipitating it as an acid addition salt upon addition of a suitable organic or mineral acid, preferably nitric acid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5387692-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5506345-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197973-B1 |
| priorityDate |
1978-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |